Hi!

As we know all too well, life sciences comms comes with a unique set of complexities, from regulatory constraints, to deep investor scrutiny, to audiences with technical expectations.

But many of the challenges we face aren’t truly one-of-a-kind to our sector. Across industries, communicators wrestle with trust, ambiguity, executive counsel under pressure, and shifting stakeholder dynamics.

Our March Comm Convo brings together communicators who have worked in and out of life sciences to share what they've learned in translation and where outside perspectives can complement our expertise.

March Comm Convo – The Outsider Advantage: Cross-Industry Comms Insights

📅 Thursday, March 26th @ Noon 1 p.m. ET / 9-10 a.m. PT / 5-6 p.m. GMT

T2B Pro & Student members (FREE): Log into your T2B account and access your promo code here.
T2B Basic members ($40): RSVP here.

Featured speakers:

💬 Lilian Anekwe, Director of Global Digital Communications, GSK​
Lilian blends deep scientific expertise with digital storytelling and strategic leadership. A former journalist and Content Curator at Facebook (Meta), her work spans digital transformation, social media, and strategic communications at one of the world’s largest biopharma companies.

💬 Alexandra Engel, Vice President, Corporate Communications, Axon​
Alex currently serves as VP and head of public relations at Axon, a global leader in public safety technology. Previously, she held leadership roles in Corporate Affairs at AstraZeneca and GSK. She helps organizations navigate growth, crisis, and complexity with credibility and clarity.

💬 Kathleen Noonan, VP, Head of Corporate Communications, ITM (Moderator)​
Kathleen’s career bridges European and Silicon Valley communications leadership, including roles at Microsoft, Siemens Energy, General Electric, Oracle, and now at ITM (Isotope Technologies Munich). She has deep experience shaping strategic narratives across tech, healthcare, and the industrial sectors.

Together, the speakers at our March Comm Convo will explore how stepping outside of the life sciences, and then back into it, can uncover fresh insights, strengthen judgment, and elevate how we advise leaders, engage audiences, and build trust.

Lynnea

​
​